References
Gornik HL, Persu A, Adlam D, Aparicio LS, Azizi M, Boulanger M, et al. First International Consensus on the diagnosis and management of fibromuscular dysplasia. Vasc Med. 2019;24:164–89.
Plouin PF, Perdu J, La Batide-Alanore A, Boutouyrie P, Gimenez-Roqueplo AP, Jeunemaitre X. Fibromuscular dysplasia. Orphanet J Rare Dis. 2007;2:1–8.
Shivapour DM, Erwin P, Kim ESH. Epidemiology of fibromuscular dysplasia: a review of the literature. Vasc Med. 2016;21:376–81.
Hendricks NJ, Matsumoto AH, Angle JF, Baheti A, Sabri SS, Park AW, et al. Is fibromuscular dysplasia underdiagnosed? A comparison of the prevalence of FMD seen in CORAL trial participants versus a single institution population of renal donor candidates. Vasc Med. 2014;19:363–7.
Tullus K. Renovascular hypertension in children. Pediatr Hypertens. 2013;371:367–77.
Pappaccogli M, Di Monaco S, Warchoł-Celińska E, Lorthioir A, Amar L, Aparicio L, et al. The European/International Fibromuscular Dysplasia Registry and Initiative (FEIRI)—clinical phenotypes and their predictors based on a cohort of 1000 patients. Cardiovasc Res. 2020;cvaa102. [Epub ahead of print].
Dobrowolski P, Januszewicz M, Witowicz H, Warchoł-Celińska E, Klisiewicz A, Skrzypczyńska-Banasik U, et al. Prevalence of smoking and clinical characteristics in fibromuscular dysplasia. The ARCADIA-POL study. Blood Press. 2019;28:49–56.
Januszewicz M, Januszewicz A, Michałowska I, Klisiewicz A, Dobrowolski P, Warchoł-Celińska E, et al. Association of intrarenal blood flow with renal function and target organ damage in hypertensive patients with fibromuscular dysplasia: The ARCADIA-POL study. Pol Arch Intern Med. 2019;129:234–41.
National Institute for Health and Care Excellence [NICE]. Hypertension in adults: diagnosis and management (NICE Guideline CG136). 2019. https://www.nice.org.uk/guidance/ng136.
Morselli F, Karunanithy N, Chowienczyk PJ, Faconti L. Do we need more vascular imaging for the screening of secondary hypertension? Mid-aortic syndrome in a young male adult. J Hum Hypertens. 2020;34:668–70.
Beregi J, Lovegny S, Gautier C, Mounier-Vehier C, Moretti A, Desmouchelle F, et al. Fibromuscular dysplasia of the renal arteries: comparison of helical CT angiography and arteriography. Am J Roentgenol. 1999;172:27–34.
Willoteaux S, Faivre-Pierret M, Moranne O, Lions C, Bruzzi J, Finot M, et al. Fibromuscular dysplasia of the main renal arteries: comparison of contrast-enhanced MR angiography with digital subtraction angiography. Radiology. 2006;241:922–9.
British and Irish Hypertension Society
Luca Faconti1, Franca Morselli1, Manish Sinha2, Constantina Chrysochou3, Philip J. Chowienczyk1
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Members of the British and Irish Hypertension Society are listed above References.
Rights and permissions
About this article
Cite this article
Faconti, L., Morselli, F., Sinha, M. et al. Fibromuscular dysplasia and hypertension—a statement on behalf of the British and Irish Hypertension Society. J Hum Hypertens 35, 1051–1053 (2021). https://doi.org/10.1038/s41371-020-00456-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41371-020-00456-6
- Springer Nature Limited